品牌资讯网欢迎您~!

设为首页

当前位置:首页>文传商讯列表

Merck Announces Mutual Decision to End Bintrafusp Alfa Agreement With GSK

时间:2021年10月09日 15:27:48

Not intended for UK- US- or Canada-based media

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced a mutual decision with GSK to terminate their agreement on bintrafusp alfa, effective September 30, 2021.

The decision is based on the clinical trial data generated to date, most notably the previously reported results from the INTR@PID Lung 037 study, which did not replicate the encouraging data observed in earlier studies. Based on the data generated during the agreement, no milestone payments were made by GSK and no future milestone obligations remain.

The INTR@PID clinical program sought to validate the potential of the novel mechanism of simultaneously blocking TGF-ß and PD-L1, with the ambition to improve outcomes for patients with difficult-to-treat cancers. Given the extent of the clinical program, Merck will deepen its scientific leadership in the field and interrogate the data leveraging the power of advanced analytics. The important insights this program has yielded about the biology of TGF-β will inform the collective understanding of this pathway.

Merck is a science-led organization dedicated to delivering transformative medicines with the goal of making a meaningful difference in the lives of people affected by cancer. Our oncology research efforts, comprised of 10 ongoing development programs, aim to leverage our synergistic portfolio in oncogenic pathways, immuno-oncology, and DNA Damage Response (DDR) to tackle challenging tumor types in gastrointestinal, genitourinary, and head and neck and thoracic cancers. Learn more at https://www.merckgrouponcology.com.

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

About Merck
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck generated sales of € 17.5 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.

来源:  作者:
相关新闻
搜狐网友:拥抱着还寂寞
评论:学习要加,骄傲要减,机会要乘,懒惰要除。

凤凰网友:控魂者*monee
评论:想让一个人对你念念不忘的话,最好的办法就是向他借钱。

百度网友:半支烟obseSSion
评论:别忘了孔雀开屏光鲜亮丽的背后却是P眼儿

网易网友:﹌假装俄狠好
评论:爷爷说他们那个年代。谁考试不会答。就答说毛主席万岁。没人敢打叉。

其它网友:拒绝得过且过
评论:男人有了烟,有了啤酒,也就有了故事;女人有了钱,有了姿色,也就有了悲剧

本网网友:請讓我們相遇
评论:有人说我懒得抽筋,其实我连抽筋都懒得抽

猫扑网友:她有我保护
评论:所谓大学:管理监狱化 素质流氓化 kiss公开化 消费白领化 上课梦境化 逃课普遍化 寝室网吧化

淘宝网友:魂牵于心  7mr°
评论:女人=吃饭+睡觉+花钱 女人=猪+花钱 女人-花钱=猪 结论:女人不花钱等于猪!

天涯网友:凊薄悢傢妇囡
评论:我也想做一个优雅的淑女,是生活把老娘逼成了泼妇.

腾讯网友:紅塵悲歡惆悵
评论:没事的话别来找我,有事那就更别来找我了。

网站介绍 | 广告刊例 | 联系我们 | 版权声明 | 网站导航

品牌资讯网版权所有 未经允许 请勿复制或镜像 Copyright © 2012-2017 http://news.ppzixunw.com/, All rights reserved.